Publications by authors named "Gina Devau"

Parkinson's disease (PD) is a progressive CNS disorder that is primarily associated with impaired movement. PD develops over decades and is linked to the gradual loss of dopamine delivery to the striatum, the loss of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc). While the administration of L-dopa and deep brain stimulation are potent therapies, their costs, side effects and gradual loss of efficacy underlines the need to develop other approaches.

View Article and Find Full Text PDF
Article Synopsis
  • Parkinson's disease (PD) is the second most common neurodegenerative disease in older adults, prompting the need for accurate animal models to study its causes and test new treatments.
  • Researchers tested canine adenovirus type 2 (CAV-2) vectors in a monkey species that naturally develops neurodegenerative issues and found that these vectors led to long-lasting, neuron-specific gene expression without triggering a significant immune response.
  • By introducing a specific mutation related to PD within the vectors, the study observed that these modified vectors caused motor symptoms and brain changes resembling Parkinson's within four months.
View Article and Find Full Text PDF

Animal models are necessary tools for solving the most serious challenges facing medical research. In aging and neurodegenerative disease studies, rodents occupy a place of choice. However, the most challenging questions about longevity, the complexity and functioning of brain networks or social intelligence can almost only be investigated in nonhuman primates.

View Article and Find Full Text PDF

Most of the signalling pathways involved in aging regulation have been recently found well conserved at various levels throughout the evolution. Taking this into account, a diversity of model organisms, including worms, rodents, and lemurs as well, allows to address different questions: how to understand the interactions between genetic and environmental factors while challenging theories of aging, to preserve hearing integrity, to fight against senescence of neural stem cells, or to explore brain fitness from gene expression to cognitive and social behavior? Here are the main issues that can be considered, stressing the complementarities of the models. The differentiation of aging physiological aspects from those induced by age-related pathologies will also be specified.

View Article and Find Full Text PDF
Article Synopsis
  • Aging is a major risk factor for neurodegenerative disorders like Alzheimer’s, but the exact molecular changes during brain aging are not well understood.
  • Researchers studied the gene expression in the temporal cortex of a primate model (Microcebus murinus) by comparing samples from young adults, healthy old animals, and old animals showing Alzheimer-like symptoms.
  • They discovered 695 genes with significant expression changes between the groups, revealing that while some genes related to metabolism were upregulated in healthy older animals, their compensatory responses were diminished in "AD-like" animals, suggesting a loss of protective mechanisms during aging.
View Article and Find Full Text PDF

Unlabelled: Analyzing microarrays data is still a great challenge since existing methods produce huge amounts of useless results. We propose a new method called NoDisco for discovering novelties in gene sequences obtained by applying data-mining techniques to microarray data.

Method: We identify popular genes, which are often cited in the literature, and innovative genes, which are linked to the popular genes in the sequences but are not mentioned in the literature.

View Article and Find Full Text PDF

Transcriptomic technologies are promising tools for identifying new genes involved in cerebral ageing or in neurodegenerative diseases such as Alzheimer's disease. These technologies produce massive biological data, which so far are extremely difficult to exploit. In this context, we propose GeneMining, a multidisciplinary methodology, which aims at developing new strategies to analyse such data, and to design interactive tools to help biologists to identify, visualize and interpret brain ageing signatures.

View Article and Find Full Text PDF

The postnatal developmental expression and the distribution of the glutamate transporters (GLAST, GLT-1 and EAAC1) were analyzed in rat vestibular nuclei (VN), at birth and during the following 4 weeks. Analyses were performed using reverse transcriptase-polymerase chain reaction and immunoblotting of GLAST, GLT-1 and EAAC1 mRNA and protein during the postnatal development of the VN neurons and their afferent connections. We also studied the distribution of each glutamate transporter in the medial and lateral VN by use of immunocytochemistry and confocal microscopy.

View Article and Find Full Text PDF

We investigated whether three calcium-binding proteins, calretinin, parvalbumin, and calbindin, could identify specific aspects of the postnatal development of the rat lateral (LVN) and medial (MVN) vestibular nuclei and their vestibular and cerebellar connections. Calretinin levels in the vestibular nuclei, increased significantly between birth and postnatal day (P) 45. In situ hybridization and immunocytochemical staining showed that calretinin-immunoreactive neurons were mostly located in the parvocellular MVN at birth and that somatic and dendritic growth occurred between birth and P14.

View Article and Find Full Text PDF